• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

amminger@unimelb.edu.au

Credentials


Position
Prof Fellow Neurobio & Neuropro Emerg Mental Dis
Centre for Youth Mental Health (Orygen)
Education
Habilitation
University of Vienna
Professional Doctorate
University of Vienna
ORCID

0000-0001-8969-4595

Prof Paul Amminger

Prof Fellow Neurobio & Neuropro Emerg Mental Dis
Centre for Youth Mental Health (Orygen)

446 Scholarly works
14 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Effects of 6-months of SSRI use on DNA-methylation and gene expression in blood
    DOI: 10.1016/j.bbi.2026.106520
  • 2026

    Journal article

    Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study
    DOI: 10.1038/s41380-025-03304-6
  • 2026

    Journal article

    Feasibility of a Stepped-Care Intervention for Those at Clinical High Risk for Psychosis in the United States
    DOI: 10.1111/eip.70120
  • 2025

    Journal article

    Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations
    DOI: 10.1038/s41537-025-00610-4
  • 2021

    Research grants (ARC, NHMRC, MRFF)

    PRE-EMPT: Prediction of Early Mental Disorder and Preventive Treatment - Centre of Research Excellence
  • 2020

    Research grants (international)

    The Cannabidiol Early Psychosis Project: A Randomised Controlled Trial
  • 2020

    Research grants (other domestic)

    Australian Early Psychosis Collaborative Consortium Clinical Registry (Cr) & Clinical Trial & Translation Network (Cttn)
Paul Amminger

Latest Honours,
Awards and Fellowships


2017
2017 RANZCP Early Career Psychiatrist award as Mentor for Dr Scott Clark Royal Australian and New Zealand College of Psychiatrists
2015
NHMRC Fellowship (NHMRCF)
2013
Fellow of the Royal Australian and New Zealand College of Psychiatrists (FRANZCP)
2011
Fast Breaking Paper In The Field Of Psychiatry/Psychology – Top 1% Of Most-Cited Papers Published During The Past Two Years Thomson Reuters Essential Science Indicators

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk Individuals
    DOI: 10.1093/schbul/sbae204
  • 2025

    Journal article

    Therapy process factors in early psychosis: The effect of working alliance on clinical symptoms and cognitive biases in Ultra High Risk young people
    DOI: 10.1016/j.schres.2025.07.031
  • 2025

    Journal article

    Perceived stigma and self-stigma in young people at ultra-high risk for psychosis: Associations with identity-related, psychological and functional outcomes
    DOI: 10.1016/j.schres.2025.08.013
  • 2025

    Journal article

    White Blood Cell Proportions Are Associated With Response to Psychosocial Therapy in Young People at Ultra-High Risk for Psychosis
    DOI: 10.1016/j.bpsgos.2025.100546
  • 2025

    Journal article

    Transdiagnostic Symptom Dimensions in Individuals at Ultra-High Risk for Psychosis: Towards Dimensional Representations of Pluripotent Risk
    DOI: 10.1111/eip.70086
  • 2025

    Journal article

    Substance use patterns among youth seeking help for mental illness: A latent class analysis
    DOI: 10.1016/j.addbeh.2025.108355

RECENT PROJECTS

  • 2023

    Research grants (ARC, NHMRC, MRFF)

    The Cannabidiol First-Episode Psychosis Study
  • 2014

    Research grants (international)

    Psyscan - Translating Neuroimaging Findings From Research Into Clinical Practice

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224